Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria.
Tongren, JE; DRAKELEY, CJ; McDonald, SL R; REYBURN, HG; Manjurano, A; Nkya, WM M; Lemnge, MM; Gowda, CD; TODD, JE; CORRAN, PH; RILEY, EM;
2006
Infection and immunity, (2006).74 1 10.1128/IAI.74.1.257-264.2006.
Conquering malaria.
Breman, J; MILLS, A; Snow, R; Mulligan, J; Mendis, K; Sharp, B; Steketee, R; White, N; Doumbo, O; Lengeler, C; Morel, C; And Marchesini, P;
2006
Disease Control Priorities in Developing Countries , World Bank and OUP (2006).
The epidemiological consequences of reducing the transmission intensity of P.falciparum.
REYBURN, H; DRAKELEY, C;
2006
Genetically Modified Mosquitoes for Malaria Control , Landes Bioscience (2006).
Moderate effect of artemisinin-based combination therapy on transmission of plasmodium falciparum.
Bousema, JT; Schneider, P; Gouagna, LC; DRAKELEY, CJ; Tostmann, A; HOUBEN, R; SUTHERLAND, CJ; Omar, SA; Sauerwein, RW;
2006
European journal of epidemiology, (2006).21,
CD4 T cell activation as a predictor for treatment failure in Ugandans with Plasmodium falciparum malaria.
Eggena, MP; HOPKINS, H; Barugahare, B; Okello, M; Ssali, F; Mugyenyi, P; Rosenthal, PJ; Cao, H; Dorsey, G;
2006
The American journal of tropical medicine and hygiene, (2006).74 1 10.4269/ajtmh.2006.74.41.
Cost-Effectiveness of Malaria Diagnosis in Sub-Saharan Africa: The Role of Rapid Diagnostic Tests. Report submitted to WHO.
Shillcutt, S; Morel, C; Coleman, P; MILLS, A; GOODMAN, C;
2006
, LSHTM (2006).
Choosing the first line drug for malaria treatment - how can cost-effectiveness analysis inform policy?.
GOODMAN, C; Abdulla, S; Coleman, P; Mubyazi, G; Kikumbih, N; Okorosobo, T; And Mills, A;
2006
Economics of Infection (2006).
Cost-Effectiveness of Malaria Diagnosis in Sub-Saharan Africa: The Role of Rapid Diagnostic Tests in Rural Settings with High Plasmodium falciparum transmission.
Shillcutt, S; Morel, C; Coleman, P; MILLS, A; GOODMAN, C;
2006
, Report to WHO (2006).
Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.
Parveen, S; Khan, MO F; Austin, SE; CROFT, SL; YARDLEY, V; Rock, P; Douglas, KT;
2005
Journal of medicinal chemistry, (2005).48 25 10.1021/jm050819t.
Maternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids.
COX, SE; Staalsoe, T; Arthur, P; Bulmer, JN; TAGBOR, H; Hviid, L; FROST, C; RILEY, EM; KIRKWOOD, BR;
2005
Tropical medicine & international health, (2005).10 12 10.1111/j.1365-3156.2005.01515.x.